# OnCo record mountaineer-03 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/mountaineer-03/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "mountaineer-03", "NCT05253651" ;
  schema:name "MOUNTAINEER-03"@en ;
  schema:description "The trial that will decide whether HER2 drugs belong in the first treatment for HER2-positive bowel cancer rather than after chemotherapy has failed."@en ;
  schema:url <https://onco.cc/trials/mountaineer-03/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05253651>, <https://doi.org/10.1016/S1470-2045(23)00150-X> ;
  onco:status "recruiting" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/colorectal/>, <https://onco.cc/cancers/her2-amplified-colorectal/> ;
  onco:technologies <https://onco.cc/technologies/her2-tyrosine-kinase-inhibitors/>, <https://onco.cc/technologies/monoclonal-antibody/>, <https://onco.cc/technologies/kinase-inhibitors/> ;
  onco:targets <https://onco.cc/targets/her2/> ;
  onco:drugs <https://onco.cc/drugs/tucatinib/>, <https://onco.cc/drugs/trastuzumab/>, <https://onco.cc/drugs/folfox/>, <https://onco.cc/drugs/bevacizumab/>, <https://onco.cc/drugs/cetuximab/>, <https://onco.cc/drugs/oxaliplatin/> ;
  onco:companies <https://onco.cc/companies/pfizer/> ;
  onco:trials <https://onco.cc/trials/mountaineer/>, <https://onco.cc/trials/destiny-crc02/> .